Physician profile
Sheeten B Doshi
NPI 1154307478
$6,883.38
in general payments reported to CMS, 2019-2025
40 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $336 · 2021: $554 · 2022: $1,116 · 2023: $835 · 2024: $2,228 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,501 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,501.28 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,097.96 | 2019-2025 | Ruby Coil, Indigo System |
| Cook Medical LLC | $739.73 | 2020-2025 | Zilver Ptx, Rosch-Uchida, Hemospray |
| Inari Medical, INC. | $694.65 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $622.36 | 2020-2025 | Entyvio |
| Abbvie INC. | $486.40 | 2019-2025 | Rinvoq |
| Cardiovascular Systems INC. | $313.22 | 2022 | |
| Boston Scientific Corporation | $299.48 | 2019-2023 | Embold Fibered |
| Stryker Corporation | $231.74 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Medtronic, INC. | $220.81 | 2023-2024 | Kyphon Express II Kyphopak Tray, Abre, Eleview |
| Ipsen Biopharmaceuticals, INC | $206.90 | 2024 | Iqirvo, Bylvay |
| Celgene Corporation | $187.51 | 2022-2024 | Zeposia |
| Madrigal Pharmaceuticals | $185.57 | 2025 | Rezdiffra |
| Aimmune Therapeutics, INC. | $181.76 | 2024-2025 | Vowst, Zenpep |
| Janssen Biotech, INC. | $142.16 | 2024-2025 | Tremfya, Stelara |
| Genzyme Corporation | $113.34 | 2024-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $106.85 | 2020-2025 | Ocaliva |
| Lilly USA, LLC | $105.24 | 2024-2025 | Omvoh |
| Sirtex Medical INC | $101.37 | 2025 | Sir-Spheres Microspheres |
| Avanos Medical | $90.80 | 2019 | |
| Shockwave Medical, INC | $87.75 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.11 | 2020-2025 | Xifaxan, Plenvu |
| Nestle Healthcare Nutrition INC. | $66.47 | 2022-2023 | |
| Ge Healthcare | $54.25 | 2022 | |
| Phathom Pharmaceuticals, INC. | $52.45 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $44.72 | 2021-2023 | |
| Capsovision, INC. | $40.03 | 2024 | Capsocam Plus |
| Celltrion USA INC. | $37.31 | 2024 | Zymfentra |
| Regeneron Healthcare Solutions, INC. | $33.79 | 2025 | Dupixent |
| Novo Nordisk INC | $32.58 | 2025 | Wegovy |
| Mallinckrodt Hospital Products INC. | $29.98 | 2024 | Terlivaz |
| Shionogi INC | $28.15 | 2019 | |
| Fresenius Kabi USA, LLC | $25.28 | 2023 | Idacio |
| Exact Sciences Corporation | $24.08 | 2025 | The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.64 | 2024 | Cyltezo |
| Digestive Care, INC. | $21.34 | 2023 | Pertzye |
| Merck Sharp & Dohme LLC | $18.38 | 2020 | |
| Pfizer INC. | $17.12 | 2019 | |
| Allergan, INC. | $14.67 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.24 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheeten Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.